Opioid receptor modulators and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9827228
APP PUB NO 20170056377A1
SERIAL NO

15207951

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL HEALTH RESEARCH INSTITUTES35 KEYAN ROAD ZHUNAN TOWN 35053

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chao, Yu-Sheng New York, US 40 435
Loh, Horace Little Canada, US 2 0
Ueng, Shau-Hua Zhunan, TW 3 1
Yeh, Shiu-Hwa Zhunan, TW 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00